Advertisement

Topics

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Lowered to "Strong Sell" at BidaskClub

15:23 EDT 5 Aug 2017 | Topix

Several other analysts also recently commented on the company. Robert W. Baird raised their target price on Achillion Pharmaceuticals from $5.00 to $10.00 and gave the company an "outperform" rating in a research note on Monday, April 24th.

Original Article: Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Lowered to "Strong Sell" at BidaskClub

NEXT ARTICLE

More From BioPortfolio on "Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Lowered to "Strong Sell" at BidaskClub"

Quick Search
Advertisement